SCHEMBL25687627

SCHEMBL25687627

C=CCc1ccc(C(C)CC)c(OC)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.61
▸ PPARA Q07869 2/20 0.61
▸ PPARG P37231 1/20 0.61
▸ PPARD Q03181 1/20 0.61
▸ TRPM8 Q7Z2W7 4/20 0.56
▸ CYP3A4 P08684 3/20 0.56
▸ PTGS1 P23219 2/20 0.56
▸ ALOX5 P09917 2/20 0.56
▸ AR P10275 1/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ TP53 P04637 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735158 0.86 ALDH1A1 (0.67) ALDH1A1PPARAPPARGPPARDTRPM8
SCHEMBL22838628 0.80 TTR (0.42) CYP3A4TSHRNPC1RAB9AALOX15
SCHEMBL18924620 0.80 KDM4E (0.42) ALDH1A1KDM4ELMNATSHR
SCHEMBL12961032 0.80 ATM (0.42) ALDH1A1PPARAPPARGCYP3A4ALOX5
SCHEMBL11143498 0.79 ALDH1A1 (0.58) ALDH1A1PPARAPPARGPPARDTRPM8
SCHEMBL1269110 0.79 ALDH1A1 (0.50) ALDH1A1PPARAPPARGPPARDTRPM8
SCHEMBL28265920 0.78 ALDH1A1 (0.69) ALDH1A1PPARAPPARGPPARDTRPM8
Methyleugenol SCHEMBL1869396 0.77 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDTRPM8
Methyleugenol SCHEMBL29376951 0.77 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDTRPM8
Methyleugenol SCHEMBL113794 0.77 ALDH1A1 (1.00) ALDH1A1PPARAPPARGPPARDTRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230189802-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS BAITS KITTRICH CORPORATION 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189802-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS BAITS CYP51A1, CYP4A22, ACHE ALDH1A1 1885/4885PPARA 878/4885PPARG 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback